| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/25/2010 | US7722876 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity |
| 05/25/2010 | US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells |
| 05/25/2010 | CA2218857C Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 05/20/2010 | WO2010057032A2 Self-assembly of protein-based biomaterials with multiple morphologies |
| 05/20/2010 | WO2010056808A2 Compositions and methods for re-programming and re-differentiating cells |
| 05/20/2010 | WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide |
| 05/20/2010 | WO2010054482A1 Immunogenic human papillomavirus compositions |
| 05/20/2010 | WO2010009440A3 Non-invasive fetal rhd genotyping from maternal whole blood |
| 05/20/2010 | US20100125130 Tumour necrosis factor binding ligands |
| 05/19/2010 | EP1689783B1 Mutated anti-cd22 antibodies and immunoconjugates |
| 05/19/2010 | EP1214097B9 Nucleic acids encoding polyepitope polypeptides |
| 05/19/2010 | CN101709306A Fusion protein containing single-stranded DNA binding protein, expression and purification methods thereof |
| 05/19/2010 | CN101709305A Expression method of a high secretory tripolymer protein |
| 05/18/2010 | US7718777 MHC-peptide complex binding ligands |
| 05/18/2010 | US7718383 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators |
| 05/18/2010 | CA2410413C Fluorescent proteins |
| 05/18/2010 | CA2266429C Hedgehog interacting proteins and uses related thereto |
| 05/18/2010 | CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit |
| 05/17/2010 | CA2686135A1 Chimeric hirudin proteins |
| 05/15/2010 | CA2739663A1 Polypeptides that bind trail-r1 and trail-r2 |
| 05/14/2010 | WO2010053763A1 Tumor-targeting peptides and uses thereof |
| 05/14/2010 | WO2010051635A1 Methods of improving the therapeutic efficacy and utility of antibody fragments |
| 05/14/2010 | WO2010018444A3 An expression vector and a method thereof |
| 05/14/2010 | CA2742808A1 Mesothelin antibody protein fusions and methods of use |
| 05/14/2010 | CA2742777A1 Methods of improving the therapeutic efficacy and utility of antibody fragments |
| 05/14/2010 | CA2741119A1 Methods and compositions for inactivating glutamine synthetase gene expression |
| 05/13/2010 | US20100121039 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 05/13/2010 | US20100119507 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/12/2010 | EP2184356A1 Method of binding protein to support using tamavidin |
| 05/12/2010 | EP2184296A1 Fibroblast growth factor (fgf23) and methods for use |
| 05/12/2010 | EP2183963A1 Method for producing plant with modified flower morphology |
| 05/12/2010 | CN1951964B Long chain recombinant human bone morphogenesis protein-2 and its preparation method and uses |
| 05/12/2010 | CN1944463B Fusion protein with alpha-interferon activity and its coded gene and use |
| 05/12/2010 | CN1903880B Antitumour vascular endothelial growth factor VEGF-E antigen, its coding gene and application |
| 05/12/2010 | CN1864746B Gene engineered poly-valence subunit vaccine of pylorus Hp AhpC-NapA and preparation method thereof |
| 05/12/2010 | CN1612895B Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours |
| 05/12/2010 | CN1590543B Thermostable Taq polymerase fragment |
| 05/12/2010 | CN101704893A Human Scurfin protein span with membrane penetration sequence, fragment and preparation method |
| 05/12/2010 | CN101153059B ELISA reagent kit for screening, diagnosis and treatment effect forecast of nasopharyngeal carcinoma |
| 05/11/2010 | CA2533440C Amplifying atp with adp-free polyphosphate-adenylate kinase fusion protein |
| 05/11/2010 | CA2335105C Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 05/11/2010 | CA2165401C Immunogenic hybrid protein oprf-oprl derived from pseudomonas aeruginosa membrane proteins |
| 05/06/2010 | WO2010051533A2 Compositions of engineered human arginases and methods for treating cancer |
| 05/06/2010 | WO2010051502A2 Light targeting molecules and uses thereof |
| 05/06/2010 | WO2010014922A3 Protein purification tags and uses thereof |
| 05/06/2010 | US20100115666 Transcriptional Repressors of Cytokinin Signaling and Their Use |
| 05/06/2010 | US20100113361 Anti-ige vaccines |
| 05/06/2010 | US20100112071 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 05/06/2010 | US20100111995 Antigen conjugates and uses thereof |
| 05/06/2010 | US20100111978 Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structure |
| 05/06/2010 | CA2779436A1 Light targeting molecules and uses thereof |
| 05/06/2010 | CA2742497A1 Compositions of engineered human arginases and methods for treating cancer |
| 05/06/2010 | CA2739568A1 Purification of acidic proteins using ceramic hydroxyapatite chromatography |
| 05/05/2010 | EP2182059A1 Rapidly degraded reporter fusion proteins |
| 05/05/2010 | EP2182003A1 Peptide capable of binding to immunoglobulin |
| 05/05/2010 | EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/05/2010 | EP2181193A1 Nanocarrier based plant transfection and transduction |
| 05/05/2010 | EP2181121A2 Chimeric antigens |
| 05/05/2010 | EP1871785B1 Compositions and methods for fusion protein separation |
| 05/05/2010 | EP1730198B1 Adzymes and uses thereof |
| 05/05/2010 | EP1248803B1 Nogo receptor-mediated blockade of axonal growth |
| 05/05/2010 | EP1060261B1 Poly zinc finger proteins with improved linkers |
| 05/05/2010 | CN1986814B Fusion expressed product of vascular inhibine and endostatin in colibacillus and its preparing method |
| 05/05/2010 | CN1920021B Preparation method of activated insulin-like growth factor-II mediated by insulin-like growth factor binding protein-6 |
| 05/05/2010 | CN1446261B Modified cytokines for use in cancer therapy |
| 05/05/2010 | CN101702908A Hiv-1蛋白酶抑制剂 Hiv-1 protease inhibitors |
| 05/04/2010 | US7709606 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
| 05/04/2010 | US7709446 Multifunctional protease inhibitors and their use in treatment of disease |
| 05/04/2010 | US7709228 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 05/04/2010 | US7709217 Mixture comprising hemopoietic cytokine specific immunnoglobulin for use in detection of infection and immunololgical disorders |
| 05/04/2010 | US7709006 Hepatitis-C virus testing |
| 05/04/2010 | CA2367636C Fusion proteins |
| 04/29/2010 | WO2010048530A2 Methods and compositions employing an iip45 targeting ligand |
| 04/29/2010 | WO2010047188A1 Process for producing l- and d-aliphatic amino acid hydroxides |
| 04/29/2010 | WO2010046783A2 A1 moiety of cholera toxin a subunit as an adjuvant for mucosal and systemic vaccines |
| 04/29/2010 | WO2010009227A3 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 04/29/2010 | WO2009149083A3 Non-hemolytic clya for excretion of proteins |
| 04/29/2010 | WO2009142460A3 Antibody-peptide fused synergibody |
| 04/29/2010 | US20100105876 Method for the oligomerisation of peptides |
| 04/29/2010 | US20100105869 Physiologically Active Polypeptide Conjugate Having Prolonged In Vivo Half-Life |
| 04/28/2010 | EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 04/28/2010 | EP2180044A1 Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity |
| 04/28/2010 | EP2179742A1 Compositions and methods for the treatment of immune related diseases |
| 04/28/2010 | EP2178920A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178919A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178918A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178913A1 Antibody or fragment thereof recognizing avitag(tm) and uses thereof |
| 04/28/2010 | EP1487854B1 Novel isoform of vascular endothelial cell growth inhibitor (vegi) |
| 04/28/2010 | CN1596266B Specific binding agents of human angiopoietin-2 |
| 04/28/2010 | CN101698852A Protein or polypeptide with function of CD137L, and gene and application thereof |
| 04/28/2010 | CN101698682A Double-functional fusion protein based on antibacterial peptide, preparation method and applicaitoin thereof |
| 04/28/2010 | CN101698681A Chimeric polypeptide with dual-targeting function and applications thereof |
| 04/27/2010 | USRE41277 protein D is an Ig receptor for human IgD and has an apparent molecular weight of 42,000; protein D can be detected in all of 116 encapsulated and non-encapsulated isolates of H. influenzae studied |
| 04/27/2010 | US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases |
| 04/27/2010 | US7705121 Chimeric human T1R3 taste receptor polypeptides and compositions containing same |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704945 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 04/27/2010 | US7704698 Human T2R51 taste receptor and related assays for identifying bitter taste modulators |
| 04/27/2010 | US7704506 Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same |